Rongqing Pan

2.0k total citations
21 papers, 679 citations indexed

About

Rongqing Pan is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Rongqing Pan has authored 21 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Hematology. Recurrent topics in Rongqing Pan's work include Cell death mechanisms and regulation (6 papers), RNA Interference and Gene Delivery (5 papers) and Acute Myeloid Leukemia Research (4 papers). Rongqing Pan is often cited by papers focused on Cell death mechanisms and regulation (6 papers), RNA Interference and Gene Delivery (5 papers) and Acute Myeloid Leukemia Research (4 papers). Rongqing Pan collaborates with scholars based in United States, China and Colombia. Rongqing Pan's co-authors include Marina Konopleva, Michael Andreeff, Vivian Ruvolo, John C. Reed, Hong Mu, Joel Johansson, Jeremy Ryan, Gwen Nichols, Anthony Letai and Kai W. Wucherpfennig and has published in prestigious journals such as Cell, Blood and Molecular Cell.

In The Last Decade

Rongqing Pan

19 papers receiving 676 citations

Peers

Countries citing papers authored by Rongqing Pan

Since Specialization

Citations

This map shows the geographic impact of Rongqing Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongqing Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongqing Pan more than expected).

Fields of papers citing papers by Rongqing Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongqing Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongqing Pan. The network helps show where Rongqing Pan may publish in the future.

Co-authorship network of co-authors of Rongqing Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Rongqing Pan. A scholar is included among the top collaborators of Rongqing Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongqing Pan. Rongqing Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Copper(II)-Complexed Polyethylenimine-Entrapped Gold Nanoparticles Enable Targeted CT/MR Imaging and Chemodynamic Therapy of Tumors 2025 ·Polymers ·Lulu He, Na Liu, Rongqing Pan, Jingyi Zhu	0
2	ZBP1 senses spliceosome stress through Z-RNA:DNA hybrid recognition 2025 ·Molecular Cell ·Jianfeng He, Yezhang Zhu, Zhichao Tian, Mengqin Liu, (unknown), (unknown), Fei Lu, Yutong Sun, Guo Ya-jun, Rongqing Pan, Yuchen Ji, Jianxiang Chen, (unknown), Juan Lin, Xingguo Liang, Chun Kim, Chun Zhou, Huipeng Jiao	4
3	Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis 2022 ·Cell ·Rongqing Pan, Jeremy Ryan, Deng Pan, Kai W. Wucherpfennig, Anthony Letai	133
4	Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3 -Mutant Acute Myeloid Leukemia 2018 ·Clinical Cancer Research ·Xuejie Jiang, Po Yee Mak, Hong Mu, Wenjing Tao, Duncan H. Mak, Steven M. Kornblau, Qi Zhang, Peter P. Ruvolo, Jared K. Burks, Weiguo Zhang, Teresa McQueen, Rongqing Pan, Hongsheng Zhou, Marina Konopleva, Jörge E. Cortes, Qifa Liu, Michael Andreeff, Bing Z. Carter	67
5	Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy 2017 ·Cancer Cell ·Rongqing Pan, Vivian Ruvolo, Hong Mu, Joel Johansson, Gwen Nichols, John C. Reed, Marina Konopleva, Michael Andreeff	204
6	MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Qi Zhang, Lina Han, Rongqing Pan, Ce Shi, Jeremy Ryan, Man Chun John, Steven M. Kurtz, Hong Mu, Vivian Ruvolo, Helen Ma, Yingchang Mi, Jeffrey Tyner, (unknown), R. Eric Davis, Michael Andreeff, Marina Konopleva	0
7	Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML 2016 ·Blood ·Qí Zhāng, Lina Han, Ce Shi, Rongqing Pan, Man Chun John, Jeremy Ryan, Stephen E. Kurtz, Hong Mu, Vivian Ruvolo, Helen Ma, Michael Andreeff, Yingchang Mi, Jeffrey Tyner, Joel Johansson, Anthony Letai, R. Eric Davis, Marina Konopleva	5
8	Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study 2016 ·Journal of Diabetes and its Complications ·Juming Lu, Linong Ji, Yufeng Li, Quanmin Li, Shanshan Lin, Xiaofeng Lv, Li Wang, Yuan Xu, Xiaohui Guo, (unknown), Li Ma, (unknown), Yingli Chen, (unknown), Qiulan Zhang, (unknown), (unknown), (unknown), Rongqing Pan, Ying Gao	20
9	Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport 2016 ·Oncotarget ·Juliana Vélez, Rongqing Pan, Jason T. C. Lee, (unknown), Marta Fernández-Suárez, (unknown), Daniel F. Jaramillo, Catalina López, Ludis Morales, William G. Bornmann, Marina Konopleva, Gerald Krystal, Michael Andreeff, Ismael Samudio	33
10	Inhibition of Mcl-1 with the pan–Bcl-2 family inhibitor (–)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia 2015 ·Blood ·Rongqing Pan, Vivian Ruvolo, Jun Wei, Marina Konopleva, John C. Reed, Maurizio Pellecchia, Michael Andreeff, Peter P. Ruvolo	111
11	Role of Mesenchymal Stem Cell Galectin 3 in the AML Tumor Microenvironment 2015 ·Blood ·Peter P. Ruvolo, Yihua Qiu, Vivian Ruvolo, Ruiyu Wang, Zhihong Zeng, Jared K. Burks, Rongqing Pan, Numsen Hail, Teresa McQueen, Suk‐Young Yoo, Steven M. Kornblau, Michael Andreeff	2
12	Mechanisms of Acquired Resistance to Venetoclax in Preclinical AML Models 2015 ·Blood ·Qi Zhang, Rongqing Pan, Lina Han, Ce Shi, Stephen E. Kurtz, Hong Mu, Helen Ma, Michael Andreeff, Joel Johansson, Jeffrey Tyner, Yingchang Mi, Marina Konopleva	4
13	BCL-2 Inhibition By ABT-199 (Venetoclax/GDC-0199) and p53 Activation By RG7388 (Idasanutlin) Reciprocally Overcome Leukemia Apoptosis Resistance to Either Strategy Alone: Efficacy and Mechanisms 2015 ·Blood ·Rongqing Pan, Vivian Ruvolo, Hong Mu, (unknown), Joel Johansson, Kensuke Kojima, Marina Konopleva, Gwen Nichols, Michael Andreeff	7
14	The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells 2014 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Peter P. Ruvolo, Vivian Ruvolo, Rodrigo Jácamo, Jared K. Burks, Zhihong Zeng, Seshagiri Duvvuri, Liran Zhou, Yihua Qiu, Kevin R. Coombes, Nianxiang Zhang, Suk Young Yoo, Rongqing Pan, Numsen Hail, Marina Konopleva, George A. Calin, Steven M. Kornblau, Michael Andreeff	30
15	Activation of p53 By Novel MDM2 Antagonist RG7388 Overcomes AML Inherent and Acquired Resistance to Bcl-2 Inhibitor ABT-199 (GDC-0199) 2014 ·Blood ·Rongqing Pan, Kensuke Kojima, (unknown), Vivian Ruvolo, Gwen Nichols, Joel Johansson, Markus Dangl, Marina Konopleva, Michael Andreeff	6
16	BCL-2-Selective BH3 Mimetic ABT-199 Is a Potent Agent For Acute Myeloid Leukemia 2013 ·Blood ·Rongqing Pan, LaKeisha Debose, Juliana M. Benito, Leonard S. Golfman, Patrick A. Zweidler‐McKay, Lina Han, Karine G. Harutyunyan, Hong Mu, Vivian Ruvolo, Eugene Park, Markus Müschen, Joel Johansson, Gautam Borthakur, Hagop M. Kantarjian, Peter P. Ruvolo, Michael Andreeff, Marina Konopleva	4
17	Suppression of Mir-93 May Regulate Anti-Oxidant Metabolism in Mesenchymal Stromal Cells Derived From Acute Myeloid Leukemia Patients. 2012 ·Blood ·Peter P. Ruvolo, Rodrigo Jácamo, Teresa McQueen, Rongqing Pan, Ismael Samudio, Marina Konopleva, Steven M. Kornblau, Ramiro Garzon, Carlo M. Croce, Michael Andreeff	1
18	Isolation,identification and characterization of a buprofezin-degrading bacterium BF3 2011 ·China Environmental Science ·Chao Li, Rongqing Pan, (unknown), (unknown), Shunpeng Li	4
19	Sequential deletion of Pichia pastoris genes by a self-excisable cassette 2011 ·FEMS Yeast Research ·Rongqing Pan, Ji Zhang, Weiliang Shen, (unknown), Shunpeng Li, Xin Yan	38
20	Study on the Atrazine-degrading Genes in Arthrobacter sp. AG1 2007 ·Chinese journal of biotechnology/Shengwu gongcheng xuebao ·Xi Dai, Jiming Jiang, Lingkun Gu, Rongqing Pan, S LI	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact